In vivo lysogenic conversion of Tox(-) Streptococcus pyogenes to Tox(+) with Lysogenic Streptococci or free phage.
about
Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversionMolecular epidemiology and genomics of group A StreptococcusEmerging methods to study bacteriophage infection at the single-cell levelEffects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus.Structure of a group A streptococcal phage-encoded virulence factor reveals a catalytically active triple-stranded beta-helixPhage-host interaction: an ecological perspectiveLysogenic transfer of group A Streptococcus superantigen gene among StreptococciGenomic sequence of C1, the first streptococcal phageConjugal transfer of the pathogenicity island ROD21 in Salmonella enterica serovar Enteritidis depends on environmental conditionsPhage Therapy - Everything Old is New AgainNovel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides.What are the limitations on the wider therapeutic use of phage?Streptococcal toxins: role in pathogenesis and disease.Inflammation boosts bacteriophage transfer between Salmonella spp.Evidence of in vivo prophage induction during Clostridium difficile infection.The prophage-encoded hyaluronate lyase has broad substrate specificity and is regulated by the N-terminal domain.Distribution of phage-associated virulence genes in pharyngeal group a streptococcal strains isolated in ItalyBeyond Bacteria: Bacteriophage-Eukaryotic Host Interactions Reveal Emerging Paradigms of Health and Disease.The disparate effects of bacteriophages on antibiotic-resistant bacteria
P2860
Q24562822-92713BF4-A0FB-4F8B-8F5F-0D5438319064Q26823667-4A2E3EB4-29CC-4A20-A30F-5C1F834067E9Q28087251-BFBFDF18-E194-4974-8E18-E92D41A2F74CQ33494191-C86DFE6A-5EBB-483E-897E-3EAC03E7C9D2Q34201820-FAD9BF1E-38C5-44AE-86BA-84A4E3B7ADB5Q34351403-F9B5E732-3A5F-49A6-8182-0ABA5C71CA3DQ34539675-F3BFD174-FB4E-45E7-846F-1CE501720390Q35005997-11DB538D-8C29-4770-9EFC-FA3FC9B65A30Q35140041-299B8C37-472E-428F-BC20-32DC39AABA43Q36171271-C483E4C4-64C1-411E-9440-03580CB2581CQ37048735-7228D038-EE81-4B8D-A3FC-2CAC7A0170B4Q37291441-C9BC3A74-92CA-4A65-A02F-FB8C12AA67F0Q38598360-B6A70005-0D77-411F-A624-88F4FF08EF85Q40290785-69D17C8E-83A5-4247-8A76-39C02A494593Q41592976-95559E84-5286-4ADB-B9EE-4338BCAD98EFQ41672703-41E67CC5-889E-4BC9-97A8-95473F811A8DQ41855693-4B0C5ADF-A167-4317-B284-5D63DE40A2C3Q55531891-C2857292-305C-4474-AF29-5E956E144665Q57283588-ED240AB5-2D7A-4405-81FC-D7DFBC531F2E
P2860
In vivo lysogenic conversion of Tox(-) Streptococcus pyogenes to Tox(+) with Lysogenic Streptococci or free phage.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
In vivo lysogenic conversion o ...... ic Streptococci or free phage.
@ast
In vivo lysogenic conversion o ...... ic Streptococci or free phage.
@en
type
label
In vivo lysogenic conversion o ...... ic Streptococci or free phage.
@ast
In vivo lysogenic conversion o ...... ic Streptococci or free phage.
@en
prefLabel
In vivo lysogenic conversion o ...... ic Streptococci or free phage.
@ast
In vivo lysogenic conversion o ...... ic Streptococci or free phage.
@en
P2860
P1476
In vivo lysogenic conversion o ...... ic Streptococci or free phage.
@en
P2093
Thomas B Broudy
Vincent A Fischetti
P2860
P304
P356
10.1128/IAI.71.7.3782-3786.2003
P407
P577
2003-07-01T00:00:00Z